M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Apricus Biosciences unveils ED product Vitaros in Sweden; To continue with Ex-US Vitaros launches throughout 2014
Pharmaceutical company Apricus Biosciences (NasdaqCM:APRI) reported on Monday the market availability in Sweden of its novel topical on-demand treatment for erectile dysfunction (ED), Vitaros.
This launch was initiated by the company's partner, Sandoz Division of the Novartis Group of...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives